tradingkey.logo

Gelteq Ltd

GELS

1.670USD

+0.050+3.09%
Fechamento 08/04, 16:00ETCotações atrasadas em 15 min
16.12MValor de mercado
PerdaP/L TTM

Gelteq Ltd

1.670

+0.050+3.09%
Mais detalhes de Gelteq Ltd Empresa
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
Informações da empresa
Código da empresaGELS
Nome da EmpresaGelteq Ltd
Data de listagemOct 29, 2024
CEOMr. Nathan Jacob Givoni
Número de funcionários7
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 29
EndereçoLevel 4
CidadeMELBOURNE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísAustralia
Código postal3205
Telefone61390873990
Sitehttps://www.gelteq.com
Código da empresaGELS
Data de listagemOct 29, 2024
CEOMr. Nathan Jacob Givoni
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Markoff (Jeffrey)
25.86%
Golik (David)
10.73%
Givoni (Nathan Jacob)
6.96%
Crestmont Pty Ltd
6.81%
Barabash Family Trust
4.67%
Other
44.97%
Investidores
Investidores
Proporção
Markoff (Jeffrey)
25.86%
Golik (David)
10.73%
Givoni (Nathan Jacob)
6.96%
Crestmont Pty Ltd
6.81%
Barabash Family Trust
4.67%
Other
44.97%
Tipos de investidores
Investidores
Proporção
Individual Investor
48.88%
Corporation
11.48%
Research Firm
0.59%
Hedge Fund
0.27%
Investment Advisor
0.25%
Other
38.53%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
15
5.80M
61.47%
+24.19K
2025Q1
15
5.80M
61.47%
+24.19K
2024Q4
13
5.78M
61.21%
+80.95K
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Markoff (Jeffrey)
2.44M
25.86%
--
--
Nov 15, 2024
Golik (David)
1.01M
10.73%
--
--
Nov 15, 2024
Givoni (Nathan Jacob)
657.09K
6.96%
--
--
Nov 15, 2024
Crestmont Pty Ltd
642.32K
6.81%
--
--
Nov 15, 2024
Barabash Family Trust
441.00K
4.67%
--
--
Nov 15, 2024
Szewach (Simon Hayden)
338.20K
3.58%
--
--
Nov 15, 2024
Olyniec (Jeffrey W.)
164.81K
1.75%
--
--
Nov 15, 2024
Wedbush Securities, Inc.
52.25K
0.55%
+1.25K
+2.45%
Mar 31, 2025
UBS Financial Services, Inc.
23.45K
0.25%
+17.25K
+278.35%
Mar 31, 2025
Citadel Advisors LLC
15.16K
0.16%
-8.58K
-36.14%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI